Background illustration for clinical trials search

Diabetic Retinopathy Clinical Trials

Browse 629 Diabetic Retinopathy clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure

for
Cardiovascular Diseases, Heart Failure, Atrial Fibrillation,
Location: Brooklyn NY, Morehead City NC, Suffolk VA, New Bern NC,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Studies in Canada for Adults With Type 2 Diabetes on Daily Insulin or With Heart Risk

for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Joliette, Montreal, Stouffville, Toronto, Brampton,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Heart Disease or Heart Risk Factors

for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Bridgeport CT, Philadelphia PA, Norfolk VA,

Sex: All

Age: 18+

Recruiting
Active & Responsive

Intraoperative OCT Guidance of Intraocular Surgery II

for
Macular Holes, Epiretinal Membrane, Diabetic Retinopathy,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT03713268

Recruiting
Active & Responsive

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

for
Diabetic Retinopathy, Retinal Vein Occlusion,
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT04505618

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

for
Center Involved Diabetic Macular Edema, Diabetic Macular Edema
Location: Deerfield Beach FL, Erie PA, La Crosse WI, Bellaire TX,
Sponsor: Ocugen

Sex: All

Age: 18+

Code: NCT05802329

Phase 1, Recruiting
Active & Responsive

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

for
Diabetic Retinopathy, Macular Edema
Location: Waterford CT, Greenville NC, Liverpool NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705607

Phase 3, Recruiting
Active & Responsive

Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy

for
Diabetic Retinopathy (DR)
Location: Jacksonville FL
Sponsor: Digital Diagnostics, Inc.

Sex: All

Age: 22+

Code: NCT07844317

Recruiting
Active & Responsive

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

for
Diabetic Retinopathy, Macular Edema
Location: Manchester CT, Springfield MA, Bloomfield NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705555

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

for
Diabetic Macular Edema (DME)
Location: Waterford CT, Hauppauge NY, Hagerstown MD,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT07734844

Phase 3, Recruiting
Active & Responsive

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

for
Eye Diseases, Retinal Disease, Glaucoma, Optic Nerve Diseases
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT06841575

Recruiting
Active & Responsive

Global Paradise System US Post Approval Study

for
Hypertension, Cardiovascular Diseases, Vascular Diseases
Location: Boston MA, Stony Brook NY, Bridgeport CT, Brooklyn NY,
Sponsor: ReCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT06297291

Recruiting
Active & ResponsiveNew

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

for
Thyroid Eye Disease (TED), Graves' Disease,
Location: Wilmington NC, Orland Park IL
Sponsor: Ethyreal Bio, Inc.

Sex: All

Age: 18+

Code: NCT07885605

Phase 1, Recruiting
Active & Responsive

CARBON: UAB Cardiovascular Research Biobank

for
Natriuretic Peptides, Cardiovascular Diseases, Hypertension,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT05067231

Recruiting
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Boston MA, Providence RI, Charleston SC, Greensboro NC,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase 2, Recruiting
Active & Responsive

Prebiotic Inulin for Late-Reproductive Individuals

for
Obesity & Overweight, Perimenopausal Women, Prebiotics, Inulin,
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: Female

Age: 40 - 55

Code: NCT07724522

Recruiting
Active & Responsive

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, New Brunswick NJ, Greenville NC,
Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All

Age: 18+

Code: NCT07081997

Phase 3, Recruiting
Active & Responsive

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

for
Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)
Location: San Luis Obispo CA
Sponsor: California Polytechnic State University-San Luis Obispo

Sex: Female

Age: 18+

Code: NCT06988306

Recruiting
Active & Responsive

Maternal Abdominal Morphology Assessment

for
Pregnancy Related, Infant Development, Pancreas, Diabetes
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: Female

Age: 18 - 54

Code: NCT06784674

Recruiting
Active & Responsive

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

for
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Location: Quincy MA, Fayetteville NC, Tamarac FL, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07157774

Phase 3, Recruiting

What are Diabetic Retinopathy clinical trials?

Some people find out they have diabetes not from a blood test, but from a routine eye exam, because retinal changes can be one of the earliest visible signs. Diabetic retinopathy clinical trials study how diabetes-related damage to the retina develops and progresses, and test different ways to protect vision as that damage occurs. Because the condition is so closely tied to blood sugar control, some of this research also looks at how managing diabetes overall affects eye health over time.

These trials often combine eye-specific measurements, like retinal imaging, with broader health tracking, since diabetic retinopathy rarely exists in isolation from the diabetes driving it.

Article preview image

Interested in learning more about diabetic retinopathy treatment? Read our guide: Diabetic Retinopathy Treatment: Injections, Laser, Surgery

Diabetic Retinopathy Treatment: Eye Injections, Laser, Surgery, and What's New

The importance of clinical trials in Diabetic Retinopathy research

Diabetic retinopathy is a leading cause of vision loss among adults with diabetes, often developing without early warning signs. Retina clinical trials like these help researchers catch and track those early changes before vision is affected, while also connecting eye health research to broader diabetes management.

Who can participate in Diabetic Retinopathy clinical trials?

Types of Diabetic Retinopathy clinical trials

Is diabetic retinopathy clinical trial eligibility different for type 1 vs. type 2 diabetes?

How to enroll in a clinical trial for Diabetic Retinopathy